NCT03437265View on ClinicalTrials.gov

A Pharmacokinetic Study of PLENVU® in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

October 5, 2020

Study Completion Date

October 5, 2020

Conditions

Pharmacokinetic

Interventions

DRUG

PLENVU powder for oral solution

PLENVU Dose 1 (1 sachet) and PLENVU Dose 2 (2 sachets)

Trial Locations (1)

NG11 6JS

Quotient Sciences (Quotient),, Ruddington

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

Norgine

INDUSTRY